AAPL 203.88 +0.14 (+0.07%)MSFT 123.45 +0.4 (+0.33%)FB 178.27 +0.03 (+0.02%)ZNGA 5.44 +0.09 (+1.59%)NVDA 186.25 +0.19 (+0.10%)WBA 54.62 -0.33 (-0.60%)GOOG 1237.48 -0.16 (-0.01%)PIH 5.25 -0.05 (-0.94%)
AAPL 203.88 +0.14 (+0.07%)MSFT 123.45 +0.4 (+0.33%)FB 178.27 +0.03 (+0.02%)ZNGA 5.44 +0.09 (+1.59%)NVDA 186.25 +0.19 (+0.10%)WBA 54.62 -0.33 (-0.60%)GOOG 1237.48 -0.16 (-0.01%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet APOP Quote Cellect Bio

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 4 6 14
ShortTermInvest 8 5 14
Cash 12 11 28
AccountReceivab 0 1 0
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 0 20 0
TotalCurrentAss 12 32 29
PPE 1 2 2
AccumulatedDepr 0 0 -1
NetPPE 1 1 1
EquityAndOtherI 0 0 0
Goodwill 0 0 0
IntangibleAsset 0 0 0
OtherLTAssets 0 0 0
TotalNonCurrent 1 2 2
TotalAssets 13 34 30
ShortTermDebt 0 0 0
AccountsPayable 0 1 2
TaxesPayable 0 0 0
AccruedLiabilit 1 0 0
DeferredRevenue 0 0 0
OtherCurrentLia 1 2 2
TotalCurrentLia 3 3 4
Debt 0 0 0
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 0 2 7
TotalNonCurrent 0 2 7
TotalLiabilitie 3 5 12
CommonStock 0 0 0
AdditionalPaidI 37 67 83
RetainedEarning -20 -36 -64
AccumulatedOthe 4 6 9
TotalStockholde 11 28 19
TotalLiabilitie 13 34 30
Cellect Biotechnology Ltd. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Cellect Biotechnology Ltd. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.